Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Markers of Inflammation in Infants Undergoing Cardiopulmonary Bypass (ProCard): an Observational Pilot Study

NCT03143348 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT03143348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03143348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Markers of Inflammation in Infants Undergoing Cardiopulmonary Bypass (ProCard): an Observational Pilot Study
Lead sponsor
University of Oklahoma
Phase
Observational
Overall status
Completed
Start date
June 4, 2017
Completion date
April 15, 2019
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiopulmonary bypass, congenital heart defect, inflammation, inflammatory response, low cardiac output syndrome